Evusheld recommended for market authorisation in EU
Recommendation based on Phase III PROVENT trial showing a significant reduction in the risk of developing symptomatic COVID-19, with protection lasting at least six months
Recommendation based on Phase III PROVENT trial showing a significant reduction in the risk of developing symptomatic COVID-19, with protection lasting at least six months
The next-gen logistics management solutions are making the global supply chains more customer-centric and sustainable
The accelerated use of technology in clinical trials and the shift towards virtual trials is here to stay
MedisimVR is a VR based medical education platform for doctors, nurses & allied health professionals. It aims to make comprehensive Virtual Reality medical simulation more accessible and affordable
The FDA decision is primarily informed by the positive results of a proof-of-concept, Phase 2a study evaluating the safety, immunogenicity, and efficacy of a single dose of 120µg RSVpreF in a human viral challenge model in healthy adults 18 to 50 years of age
Arum's research focuses on the discovery of new chemical entities that will act as effective therapies for drug-resistant cancers
Christian brings a unique level of experience and expertise from a 20-year career at BASF across multiple territories and businesses
Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre In conversation with Thomas C Thottathil, Editor, www.indianpharmapost.com identified key areas that the company is focusing on in its Mission 2025
The approval is based on new data from cohorts D and K of the KEYNOTE-158 trial
Submissions for Ruminant Well-Being Awards and Gustav Rosenberger Memorial Fund grant open now
Subscribe To Our Newsletter & Stay Updated